BioCentury
ARTICLE | Company News

Shire's firepower

February 13, 2015 2:32 AM UTC

Shire plc (LSE:SHP; NASDAQ:SHPG) CEO Flemming Ornskov said on Thursday's conference call to discuss 4Q14 earnings that the company still has "significant firepower to do additional M&A" in the wake of its acquisition of NPS Pharmaceuticals Inc. (NASDAQ:NPSP). CFO Jeff Poulton said the company's net debt position will allow it to fund more M&A deals.

Total product sales in 2014 jumped 23% to $5.8 billion from $4.8 billion in 2013, despite the negative impact of foreign exchange rates and generic competition for ADHD drug Intuniv guanfacine extended release. ...